DE602006006030D1 - Neue makrolide - Google Patents

Neue makrolide

Info

Publication number
DE602006006030D1
DE602006006030D1 DE602006006030T DE602006006030T DE602006006030D1 DE 602006006030 D1 DE602006006030 D1 DE 602006006030D1 DE 602006006030 T DE602006006030 T DE 602006006030T DE 602006006030 T DE602006006030 T DE 602006006030T DE 602006006030 D1 DE602006006030 D1 DE 602006006030D1
Authority
DE
Germany
Prior art keywords
new
makrolide
antibiotics
diseases
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006006030T
Other languages
English (en)
Inventor
Johannes Laurenz Kellenberger
Stuart Robert Shapiro
Salima Mathews
Philippe Guerry
Pierre Jacques Barbier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Basilea Pharmaceutica AG
Original Assignee
Basilea Pharmaceutica AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basilea Pharmaceutica AG filed Critical Basilea Pharmaceutica AG
Publication of DE602006006030D1 publication Critical patent/DE602006006030D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Steroid Compounds (AREA)
  • Peptides Or Proteins (AREA)
DE602006006030T 2005-02-09 2006-02-08 Neue makrolide Active DE602006006030D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05002664 2005-02-09
EP05011419 2005-05-26
PCT/CH2006/000083 WO2006084410A1 (en) 2005-02-09 2006-02-08 New macrolides

Publications (1)

Publication Number Publication Date
DE602006006030D1 true DE602006006030D1 (de) 2009-05-14

Family

ID=36204543

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006006030T Active DE602006006030D1 (de) 2005-02-09 2006-02-08 Neue makrolide

Country Status (17)

Country Link
US (1) US7524823B2 (de)
EP (1) EP1846430B1 (de)
JP (1) JP5112079B2 (de)
KR (1) KR101139751B1 (de)
AT (1) ATE427315T1 (de)
AU (1) AU2006212626B2 (de)
CA (1) CA2597327C (de)
CY (1) CY1109187T1 (de)
DE (1) DE602006006030D1 (de)
DK (1) DK1846430T3 (de)
ES (1) ES2322775T3 (de)
HR (1) HRP20090302T1 (de)
MX (1) MX2007008549A (de)
PL (1) PL1846430T3 (de)
SI (1) SI1846430T1 (de)
TW (1) TWI389916B (de)
WO (1) WO2006084410A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2428874T3 (es) * 2006-08-09 2013-11-12 Basilea Pharmaceutica Ag Nuevos macrólidos útiles contra las enfermedades inflamatorias y alérgicas
EP2056844A4 (de) * 2006-08-24 2010-11-24 Wockhardt Research Center Neue makrolide und ketolide mit antimikrobieller wirkung
MX2010008751A (es) * 2008-02-08 2010-08-31 Basilea Pharmaceutica Ag Macrolidos para tratamiento de enfermedades mediadas a traves de inhibicion de pde.
US8410065B2 (en) 2008-02-08 2013-04-02 Basilea Pharmaceutica Ag Macrolides and their use
WO2009130189A1 (en) * 2008-04-23 2009-10-29 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. 2'-o,3'-n-bridged macrolides
KR101566053B1 (ko) * 2009-05-27 2015-11-04 욱크하르트 리미티드 항균 활성을 갖는 케톨라이드
CA2769551A1 (en) 2009-08-13 2011-02-17 Basilea Pharmaceutica Ag New macrolides and their use
PL2938623T3 (pl) * 2012-12-31 2017-03-31 Basilea Pharmaceutica Ag Wybrane makrolidy o działaniu hamującym pde4

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001282105A1 (en) 2000-08-22 2002-03-04 Basilea Pharmaceutica Ag New macrolides with antibacterial activity
WO2003004509A2 (en) * 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
WO2003061671A1 (en) * 2002-01-17 2003-07-31 Kosan Biosciences, Inc. Amido macrolides
US6995143B2 (en) 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
DE102004002638A1 (de) 2004-01-19 2005-08-18 Merck Patent Gmbh Kombinationen von Serotonin-Wiederaufnahme-Hemmern und Imidazolin-I2-Agonisten

Also Published As

Publication number Publication date
JP2008530035A (ja) 2008-08-07
CA2597327C (en) 2012-02-07
MX2007008549A (es) 2007-08-14
DK1846430T3 (da) 2009-06-22
WO2006084410A1 (en) 2006-08-17
CA2597327A1 (en) 2006-08-17
AU2006212626A1 (en) 2006-08-17
TW200640942A (en) 2006-12-01
HRP20090302T1 (en) 2009-07-31
EP1846430B1 (de) 2009-04-01
PL1846430T3 (pl) 2009-08-31
US20060264387A1 (en) 2006-11-23
CY1109187T1 (el) 2014-07-02
KR101139751B1 (ko) 2012-04-26
EP1846430A1 (de) 2007-10-24
KR20070113206A (ko) 2007-11-28
ES2322775T3 (es) 2009-06-26
ATE427315T1 (de) 2009-04-15
US7524823B2 (en) 2009-04-28
SI1846430T1 (sl) 2009-08-31
JP5112079B2 (ja) 2013-01-09
AU2006212626B2 (en) 2010-04-29
TWI389916B (zh) 2013-03-21

Similar Documents

Publication Publication Date Title
GB0625648D0 (en) Compounds
ATE427315T1 (de) Neue makrolide
EA200901032A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
EA201170521A1 (ru) Новые соединения
GT200900095A (es) Dihidropirazolonas sustituidas para el tratamiento de enfermedades cardiovasculares y hermatologicas.
NZ593111A (en) Antibacterial compounds
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
EA201100138A1 (ru) 4-феноксиметилпиперидины в качестве модуляторов активности gpr119
MX2012004525A (es) Compuestos.
MA32811B1 (fr) Nouveaux composés
TW200745043A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
CL2008002384A1 (es) Compuestos derivados de quinoliniloxipiperidina y pirrolidina, composicion farmaceutica, combinacion farmaceutica, util para el tratamiento de enfermedades inflamatorias y/o alergicas del tracto respiratorio.
UY29358A1 (es) Tiazolidinonas, su preparacion y su uso como medicamento
UY29189A1 (es) Nonadepsipeptidos acilados ii
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
DE502005010850D1 (de) Antibakterielle amid-makrozyklen iv
TW200745042A (en) Substituted pyrazoline compounds, their preparation and use as medicaments
ME00582A (en) Tricyclic compound and pharmaceutical use thereof
DE502005005652D1 (de) Heterocyclyl-substituierte nonadepsipeptide
ATE455789T1 (de) Substituierte nonadepsipeptide
MX2011008074A (es) Macrolido anti-inflamatorio.
MX2009013482A (es) Derivados de [1,10]-fenantrolina para el tratamiento de enfermedades neurodegenerativas o hematologicas.
ATE524488T1 (de) Lysobactinamide
ATE474574T1 (de) Imidazoazephinonverbindungen
FR2943537B1 (fr) Traitement des nevrites vestibulaires par l'acetyl-l-leucine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition